Antiangiogenesis in Myelodysplastic Syndrome

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|11|9|1044-1052

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.11, Iss.9, 2011-01, pp. : 1044-1052

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Azacitidine beneficial in myelodysplastic syndrome

By  

Inpharma, Vol. 1, Iss. 1348, 2002-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Iobenguane: Myelodysplastic syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1233, 2009-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Antiretrovirals: Myelodysplastic syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1261, 2009-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Imatinib: Myelodysplastic syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1264, 2009-01 ,pp. : 20-21

Adis International

Access to resources Recommend Favorite

Cyclophosphamide: Myelodysplastic syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1303, 2010-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite